Oncorus Inc. (ONCR) concluded trading on 01/11/23 at a closing price of $0.31, with 0.59 million shares of worth about $0.18 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -75.59% during that period and on Wednesday the price saw a gain of about 3.40%. Currently the company’s common shares owned by public are about 25.97M shares, out of which, 23.66M shares are available for trading.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 22 times over the past 12 months. They bought 49,000 shares in 7 of the transactions. In 15 selling transactions, insiders dumped 87,170 shares.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
Vanguard Total Stock Market Index, Vanguard Extended Market Index Fu, and iShares Biotechnology ETF are the top 3 mutual funds which are holding stakes in Oncorus Inc. Vanguard Total Stock Market Index is currently holding 0.26 million shares of worth totaling $0.13 million. The company recently came buying 0.0 shares which brought its stake up to 1.02% of the company’s outstanding shares. iShares Biotechnology ETF, after buying 0.13 million shares, have now control over 0.49% of the stake in the company. It holds 665.0 shares of worth $60632.0.
However, the stock later moved at a day high price of 0.3450, or with a gain of 3.40%. Stock saw a price change of 3.33% in past 5 days and over the past one month there was a price change of -22.50%. Year-to-date (YTD), ONCR shares are showing a performance of 22.38% which decreased to -93.40% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.23 but also hit the highest price of $4.68 during that period. The average intraday trading volume for Oncorus Inc. shares is 112.52K. The stock is currently trading 2.57% above its 20-day simple moving average (SMA20), while that difference is down -32.36% for SMA50 and it goes to -70.87% lower than SMA200.
Oncorus Inc. (NASDAQ: ONCR) currently have 25.97M outstanding shares and institutions hold larger chunk of about 65.20% of that. Holding of mutual funds in the company is about 3.34% while other institutional holders and individual stake holders have control over 34.39% and 24.19% of the stake respectively.
The stock has a current market capitalization of $8.09M. It has posted earnings per share of -$2.95 in the same period. It has Quick Ratio of 5.00 while making debt-to-equity ratio of 0.24. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ONCR, volatility over the week remained 14.78% while standing at 16.01% over the month.
Analysts are in expectations that Oncorus Inc. (ONCR) stock would likely to be making an EPS of -$0.75 in the current quarter, while forecast for next quarter EPS is -$0.7 and it is -$1.96 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.84 which is -$0.69 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.65 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 2.00% while it is estimated to increase by 43.90% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Maxim Group on March 16, 2021 offering a Buy rating for the stock and assigned a target price of $35 to it. Coverage by Piper Sandler stated Oncorus Inc. (ONCR) stock as an Overweight in their note to investors on October 27, 2020, suggesting a price target of $40 for the stock. On October 27, 2020, Jefferies Initiated their recommendations, while on October 27, 2020, Evercore ISI Initiated their ratings for the stock with a price target of $35.
